Mono Pharmacare Profit & Loss Annual

BSE: - | NSE: MONOPHARMA | ISIN: INE0OIP01012 | Sector: -
24.30 - (-4.89%)Updated : 14 Jul 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Total Operating Expense 116.1355.6135.8127.55
Other Net -0.140.030.030.10
Total Adjustmentsto Net Income 0.00---
Diluted Weighted Average Shares 1.541.771.771.77
Depreciation/ Amortization 0.120.100.110.13
Operating Income 6.212.861.170.72
Net Income 2.441.230.350.10
Income Availableto Com Excl Extra Ord 2.441.230.350.10
Other Operating Expenses Total 1.821.070.390.32
Net Income Before Taxes 3.231.680.550.17
Minority Interest -0.020.000.000.00
Net Income After Taxes 2.461.230.350.10
Income Availableto Com Incl Extra Ord 2.441.230.350.10
Costof Revenue Total 110.6853.3434.6926.56
Gross Profit 11.665.142.291.71
Interest Inc( Exp) Net- Non- Op Total -2.85-1.22-0.65-0.64
Unusual Expense( Income) 0.000.000.000.00
Diluted Net Income 2.441.230.350.10
Provisionfor Income Taxes 0.770.440.200.07
period Type ----
Net Income Before Extra Items 2.441.230.350.10
Total Revenue 122.3458.4836.9828.27
period Length 12.0012.0012.0012.00
Revenue 122.3458.4836.9828.27
Selling/ General/ Admin Expenses Total 3.511.100.620.54
Diluted Normalized EPS 1.590.700.200.05
Diluted EPS Excluding Extra Ord Items 1.590.700.200.05
*All figures in crores except per share values
Recommended For You
Trending Stocks
881.90+14.75(1.70%)
258.45+4.30(1.69%)
1,566.10-53.85 (-3.32%)
159.50-0.85 (-0.53%)